Literature DB >> 10466970

Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks.

C Rogier1, A B Ly, A Tall, B Cissé, J F Trape.   

Abstract

Six hundred eighty-nine Plasmodium falciparum malaria attacks were observed during a three-year period among 226 inhabitants of the village of Dielmo, Senegal, an area of high malaria transmission. Malaria attacks were defined as clinical episodes with fever (body temperature > or = 38.0 degrees C) or reporting of fever or headache or vomiting, associated with a parasite:leukocyte ratio above an age-dependent pyrogenic threshold identified in this population. The symptom frequencies were tested against age, gender, and parasite density using a random-effect logistic regression model and the study of distinguishable clinical presentations was carried out by multi-correspondence analysis. There was little difference between the severity of symptoms during the initial course of attacks in young children and adults, and this severity was not correlated with the duration of the pathologic episode. It was not possible to distinguish objectively different malaria attack types according to the severity of clinical manifestations. In contrast, the duration of fever, symptoms, and parasite clearance were significantly longer among the youngest children than among the oldest children and adults. These findings suggest that of the two components of protective immunity, anti-parasite immunity and anti-toxic immunity, only the first would play a major role as age increases. They suggest also that the initial clinical presentation of malaria attacks is not predictive of the level of protective immunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466970     DOI: 10.4269/ajtmh.1999.60.410

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  28 in total

1.  The potential impact of integrated malaria transmission control on entomologic inoculation rate in highly endemic areas.

Authors:  G F Killeen; F E McKenzie; B D Foy; C Schieffelin; P F Billingsley; J C Beier
Journal:  Am J Trop Med Hyg       Date:  2000-05       Impact factor: 2.345

2.  High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals.

Authors:  P H Consigny; B Cauquelin; P Agnamey; E Comby; P Brasseur; J J Ballet; C Roussilhon
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Dramatic Changes in Malaria Population Genetic Complexity in Dielmo and Ndiop, Senegal, Revealed Using Genomic Surveillance.

Authors:  Amy K Bei; Makhtar Niang; Awa B Deme; Rachel F Daniels; Fatoumata D Sarr; Cheikh Sokhna; Cheikh Talla; Joseph Faye; Nafissatou Diagne; Souleymane Doucoure; Souleymane Mboup; Dyann F Wirth; Adama Tall; Daouda Ndiaye; Daniel L Hartl; Sarah K Volkman; Aissatou Toure-Balde
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

4.  Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.

Authors:  Charlotte Joos; Laurence Marrama; Hannah E J Polson; Sandra Corre; Antoine-Marie Diatta; Babacar Diouf; Jean-François Trape; Adama Tall; Shirley Longacre; Ronald Perraut
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

5.  Changing malaria epidemiology and diagnostic criteria for Plasmodium falciparum clinical malaria.

Authors:  Clémentine Roucher; Christophe Rogier; Fambaye Dieye-Ba; Cheikh Sokhna; Adama Tall; Jean-François Trape
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

6.  Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges.

Authors:  Quique Bassat; Raquel González; Sónia Machevo; Alain Nahum; John Lyimo; Hamma Maiga; Andreas Mårtensson; Mahfudh Bashraheil; Peter Ouma; David Ubben; Verena Walter; Obiyo Nwaiwu; Chemtai Kipkeu; Gilbert Lefèvre; Bernhards Ogutu; Clara Menéndez
Journal:  Malar J       Date:  2011-12-16       Impact factor: 2.979

7.  Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.

Authors:  Adama Tall; Cheikh Sokhna; Ronald Perraut; Didier Fontenille; Laurence Marrama; Alioune B Ly; Fatoumata D Sarr; Aïssatou Toure; Jean-François Trape; André Spiegel; Christophe Rogier; Pierre Druilhe
Journal:  Malar J       Date:  2009-07-15       Impact factor: 2.979

8.  The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives.

Authors:  Ricardo Aguas; José M L Lourenço; M Gabriela M Gomes; Lisa J White
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

9.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

10.  Prospects for malaria eradication in sub-Saharan Africa.

Authors:  Ricardo Aguas; Lisa J White; Robert W Snow; M Gabriela M Gomes
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.